Clinical Trials Browser

Phase 1/2 × Neuroblastoma × TPI-287 × Clear all

NCT01505608 2024-08-06

Randomized Efficacy Study of TPI 287 to Treat Primary Refractory or Early Relapsed Neuroblastoma

Phase 1/2 Terminated

14 enrolled 11 charts

Neuroblastoma